|
|
| 上海君实生物医药科技股份有限公司- H股, 01877.HK - 综合资产负债表 |
2022-12 |
2021-12 |
2020-12 |
2019-12 |
2018-12 |
2017-12 |
2016-12 |
| 固定资产 |
3,278,456 |
3,069,792 |
2,534,394 |
2,007,386 |
939,341 |
359,626 |
168,549 |
| 投资 |
1,402,836 |
1,484,900 |
422,896 |
141,591 |
19,027 |
5,354 |
222,904 |
| 流动资产 |
7,204,905 |
5,831,739 |
4,698,717 |
1,911,116 |
2,910,184 |
511,006 |
544,908 |
| 其他资产 |
690,089 |
664,289 |
354,857 |
362,347 |
388,758 |
343,723 |
212,669 |
| 总资产 |
12,576,286 |
11,050,720 |
8,010,864 |
4,422,440 |
4,257,310 |
1,219,709 |
1,149,030 |
| 长期债项 |
886,167 |
583,127 |
573,213 |
772,228 |
391,763 |
0 |
0 |
| 其他长期负债 |
121,615 |
118,776 |
103,809 |
56,320 |
73,349 |
41,815 |
3,453 |
| 流动负债 |
1,774,254 |
2,016,635 |
1,492,582 |
605,376 |
471,065 |
58,560 |
18,962 |
| 股本 |
982,872 |
910,757 |
872,496 |
784,147 |
760,310 |
584,750 |
550,000 |
| 储备 |
8,518,544 |
7,050,146 |
4,968,767 |
2,204,372 |
2,561,936 |
535,758 |
577,562 |
| 股东权益 |
9,501,416 |
7,960,903 |
5,841,263 |
2,988,519 |
3,322,246 |
1,120,508 |
1,127,562 |
| 货币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
| 单位 |
| 主要项目 |
| 存货 |
599,021 |
484,601 |
343,425 |
180,666 |
48,468 |
30,603 |
7,086 |
| 现金及银行结存 |
6,028,022 |
3,505,064 |
3,384,998 |
1,220,854 |
2,763,570 |
293,259 |
115,437 |
| 短期债项 |
435,414 |
45,068 |
277,566 |
90,737 |
178,632 |
0 |
20 |
| 总债项 |
1,321,581 |
628,195 |
850,779 |
862,965 |
570,395 |
0 |
20 |
| 核数师意见 |
1 |
1 |
1 |
1 |
1 |
0 |
0 |
说明：1代表无保留意见；2代表保留意见；3代表修改意见
|
|
